IBCP:NASDAQIndependent Bank Corporation Analysis
Data as of 2026-06-14 - not real-time
$35.48
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
IBCP is trading at $35.48, comfortably above its 20‑day SMA of $34.20 and 50‑day SMA of $34.02, while the 200‑day SMA sits near $33.29, indicating a clear bullish trend. The RSI of 62 suggests continued upward momentum without being overbought, and the MACD histogram is positive (0.17) with a bullish signal line crossover. Volume is increasing, beta is modest at 0.71 and 30‑day volatility is about 22.7%, supporting a stable price move within the $32.45 support and $39.17 resistance range.
Fundamentally, IBCP trades at a forward PE of 9.27 versus an industry average of 16.83, and its dividend yield of 3.16% with a payout ratio of 31.7% appears sustainable. The DCF fair value of $38.15 implies modest upside (~3%) and the recent merger agreement to acquire HCB Financial Corp. could add earnings accretion and scale. Combined with a 9.7% revenue growth and solid operating margins, the stock looks undervalued and positioned for both income and capital appreciation.
Fundamentally, IBCP trades at a forward PE of 9.27 versus an industry average of 16.83, and its dividend yield of 3.16% with a payout ratio of 31.7% appears sustainable. The DCF fair value of $38.15 implies modest upside (~3%) and the recent merger agreement to acquire HCB Financial Corp. could add earnings accretion and scale. Combined with a 9.7% revenue growth and solid operating margins, the stock looks undervalued and positioned for both income and capital appreciation.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish technical setup (price above SMA, positive MACD)
- Increasing volume supporting momentum
- Support level comfortably above current price
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Accretive merger with HCB Financial expanding asset base
- Attractive dividend yield with sustainable payout
- Valuation discount to industry peers (low PE, fair value upside)
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Stable low‑beta profile for defensive positioning
- Consistent profitability and cash flow generation
- Long‑term dividend growth potential
Key Metrics & Analysis
Financial Health
Revenue Growth9.70%
Profit Margin31.08%
P/E Ratio10.6
ROE14.28%
ROA1.28%
P/B Ratio1.4
Op. Cash Flow$48.3M
Industry P/E16.8
Technical Analysis
TrendBullish
RSI62.4
Support$32.45
Resistance$39.17
MA 20$34.20
MA 50$34.02
MA 200$33.29
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86
Valuation
Fair Value$38.15
Target Price$36.70
Upside/Downside3.44%
GradeUndervalued
TypeValue
Dividend Yield3.16%
Risk Assessment
Beta0.71
Volatility22.71%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.